InMed Pharmaceuticals, Inc. (INM)

1.55 -0.04 (-2.52%) USD  |  NASDAQ  |  Jun 04, 15:21
More

InMed Pharmaceuticals Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for INM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Manzo Pharmaceuticals, Inc. --
Clearmind Medicine, Inc. Upgrade
Pharmagreen Biotech, Inc. Upgrade